Perspective Therapeutics (CATX) EBT Margin Growth (1y) (2011 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -419.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 110.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -300.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -287.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 233.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 772.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -464.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 584.00
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 -23,703.00
Jun 30, 2023 -65,745.00
Mar 31, 2023 -54,776.00
Sep 30, 2022 -14,944.00
Jun 30, 2022 -13,262.00
Mar 31, 2022 -1,763.00
Dec 31, 2021 -2,016.00
Sep 30, 2021 -5,757.00
Jun 30, 2021 10,180.00
Mar 31, 2021 -973.00
Dec 31, 2020 387.00
Sep 30, 2020 534.00
Jun 30, 2020 478.00
Mar 31, 2020 3,976.00
Dec 31, 2019 3,360.00
Sep 30, 2019 6,129.00
Jun 30, 2019 9,019.00
Mar 31, 2019 2,600.00
Dec 31, 2018 2,098.00
Sep 30, 2018 3,112.00
Jun 30, 2018 -1,316.00
Mar 31, 2018 2,141.00
Dec 31, 2017 4,580.00
Sep 30, 2017 1,526.00
Jun 30, 2017 -2,662.00
Mar 31, 2017 18.00
Dec 31, 2016 -2,717.00
Sep 30, 2016 -6,077.00
Jun 30, 2016 -3,020.00
Mar 31, 2016 -2,145.00
Dec 31, 2015 -2,492.00
Sep 30, 2015 2,262.00
Jun 30, 2015 6,081.00
Mar 31, 2015 233.00
Dec 31, 2014 722.00
Sep 30, 2014 1,284.00
Jun 30, 2014 -5,576.00
Mar 31, 2014 -2,129.00
Dec 31, 2013 1,652.00
Sep 30, 2013 -1,133.00
Jun 30, 2013 -624.00
Mar 31, 2013 -770.00
Dec 31, 2012 -4,801.00
Sep 30, 2012 -1,545.00
Jun 30, 2012 -1,312.00
Mar 31, 2012 333.00
Dec 31, 2011 -1,263.00
Sep 30, 2011 -2,514.00